Publications by authors named "Minoru Fukuda"

Claim this Profile
A
A phase II clinical trial on the efficacy and safety of carboplatin plus nab-paclitaxel in chemotherapy-naive advanced or recurrent thymic epithelial tumors: protocol of Nab-TET.
Fumiko Hayashi, Midori Matsuo, Shinnosuke Takemoto, Ryosuke Ogata, Yasuhiro Umeyama, Minoru Fukuda

J Thorac Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral and cellular immune responses to mRNA COVID-19 vaccinations in the elderly: A longitudinal study in Japan.
Kiyoyasu Fukushima, Toru Kubo, Yuta Ito, Yoshie Oda, Yohsuke Nagayoshi, Minoru Fukuda

J Infect Chemother· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of ramucirumab and docetaxel for previously platinum-treated patients with non-small cell lung cancer and malignant pleural effusion (PLEURAM study).
Shinnosuke Takemoto, Minoru Fukuda, Ryosuke Ogata, Hiroaki Senju, Nanae Sugasaki

Transl Lung Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated immunoassay of serum NY-ESO-1 and XAGE1 antibodies for predicting clinical benefit with immune checkpoint inhibitor (ICI) in advanced non-small cell lung cancer.
Kanako Sakaeda, Koji Kurose, Yuki Matsumura, Satoshi Muto, Minoru Fukuda, Masaaki Fukuda

Cancer Treat Res Commun· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Nocardiosis Caused by Nocardia sputorum Identified via 16S rRNA Gene Sequencing: A Case Report.
Satoshi Irifune, Shotaro Ide, Satoru Koga, Keisuke Mine, Nanae Sugasaki, Minoru Fukuda

Cureus· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2 Single-Arm Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis NSCLC: Results for the First-Line Cohort of the OCEAN Study (LOGIK 1603/WJOG 9116L).
Kazushige Wakuda, Hiroyuki Yamaguchi, Hirotsugu Kenmotsu, Minoru Fukuda, Kentaro Ito

JTO Clin Res Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of IRInotecan treatment after COmbined chemo-immunotherapy for extensive-stage small cell lung cancer: Protocol of IRICO study.
Hiromi Tomono, Hirokazu Taniguchi, Minoru Fukuda, Takaya Ikeda, Seiji Nagashima

Thorac Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic profile of thymic epithelial tumors in the Japanese population: an exploratory study examining potential therapeutic targets.
Midori Shimada, Hirokazu Taniguchi, Hiroyuki Yamaguchi, Hiroshi Gyotoku, Daisuke Sasaki, Minoru Fukuda

Transl Lung Cancer Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgically resected lung adenocarcinoma: do heterogeneous GGNs and part-solid nodules on thin-section CT show different prognosis?
Hirofumi Koike, Kazuto Ashizawa, Shin Tsutsui, Minoru Fukuda, Shinji Okano

Jpn J Radiol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: Serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers.
Koji Kurose, Kanako Sakaeda, Minoru Fukuda, Yumiko Sakai, Hiroyuki Yamaguchi

Adv Clin Chem· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proportion of biopsy specimens containing a tumor when compared to all biopsy specimens by transbronchial biopsy.
Shinnosuke Takemoto, Mutsumi Ozasa, Remi Mizuta, Ryuta Tagawa, Sawana Ono, Minoru Fukuda

Lung Cancer Manag· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients: The SPIRAL-0 Study.
Yusuke Chihara, Takayuki Takeda, Yasuhiro Goto, Yoichi Nakamura, Yuko Tsuchiya-Kawano, Minoru Fukuda

Oncologist· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Results of the LOGIK1605/JART-1501 study.
Minoru Fukuda, Masafumi Yamaguchi, Takuya Yamazaki, Soichiro Funaki, Hiroshi Mukae

Thorac Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-disease small cell lung cancer: protocol of ACIST study.
Kazumasa Akagi, Hirokazu Taniguchi, Minoru Fukuda, Takuya Yamazaki, Sawana Ono

Thorac Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Wasted Anti-Cancer Agents Due to Cancellations after Dispensing].
Minoru Fukuda, Takuya Honda, Takahiro Uchida, Seiichi Nose, Yukinobu Kodama

Gan To Kagaku Ryoho· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis From NSCLC: Results for the T790M Cohort of the OCEAN Study (LOGIK1603/WJOG9116L).
Hiroyuki Yamaguchi, Kazushige Wakuda, Minoru Fukuda, Hirotsugu Kenmotsu, Hiroshi Mukae

J Thorac Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of S-1 after pemetrexed in patients with non-small cell lung cancer: A retrospective multi-institutional analysis.
Shinnosuke Takemoto, Kazumasa Akagi, Sawana Ono, Hiromi Tomono, Noritaka Honda, Minoru Fukuda

Thorac Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor.
Yosuke Dotsu, Hiroyuki Yamaguchi, Minoru Fukuda, Takayuki Suyama, Noritaka Honda

J Clin Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel automated immunoassay for serum NY-ESO-1 and XAGE1 antibodies in combinatory prediction of response to anti-programmed cell death-1 therapy in non-small-cell lung cancer.
Yumiko Sakai, Koji Kurose, Kanako Sakaeda, Hirotaka Abo, Yusuke Atarashi, Minoru Fukuda

Clin Chim Acta· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tracheal Paraganglioma: A Case report and Review of the Pertinent Literature.
Masatsugu Kamada, Aya Shimamoto, Mio Mori, Shin Tsutsui, Yoshiaki Zaizen, Minoru Fukuda

Intern Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of comprehensive analysis with circulating tumor DNA in advanced non-small cell lung cancer patients considered for osimertinib treatment.
Naoko Sueoka-Aragane, Chiho Nakashima, Hironori Yoshida, Naohisa Matsumoto, Kentaro Iwanaga, Minoru Fukuda

Cancer Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remarkable response to pembrolizumab with platinum-doublet in PD-L1-low pulmonary sarcomatoid carcinoma: A case report.
Hirokazu Taniguchi, Shinnosuke Takemoto, Mutsumi Ozasa, Noritaka Honda, Takayuki Suyama, Minoru Fukuda

Thorac Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.
Yosuke Dotsu, Minoru Fukuda, Noritaka Honda, Hiroshi Gyotoku, Yoshihisa Kohno

Thorac Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming the blood-brain barrier by Annexin A1-binding peptide to target brain tumours.
Motohiro Nonaka, Misa Suzuki-Anekoji, Jun Nakayama, Hideaki Mabashi-Asazuma, Donald L Jarvis, Minoru Fukuda, Michiko N Fukuda

Br J Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Trends in Outpatient Chemotherapy for Thoracic Oncology].
Minoru Fukuda, Hiroyuki Yamaguchi, Shinnosuke Takemoto, Hiroaki Senju, Hiroshi Gyotoku

Gan To Kagaku Ryoho· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis